A recent systematic review has reignited debate about what happens when patients stop taking GLP-1 RAs and related incretin therapies.
The Therapeutic Goods Administration (TGA) has today (Monday 1 December) made updates to product warnings for GLP-1 and dual GIP/GLP-1 receptor agonists for two...
Pharmacists are helping detect CKD sooner through point-of-care testing and risk assessment that connect at-risk patients with their GP.
Chronic kidney disease (CKD) is a...
Questions about spacers are abundant in community pharmacy. AP answers some of the trickiest ones pharmacists face.
The various dementias are a huge cause of death in Australia. Despite some light on the horizon, there are still no effective treatments.
Administered to the nasal mucosa, a spike-based formulation triggers rapid local defences that clear the COVID-19 virus where it enters.
In 2022, a year after...
Patients often find creative ways to remember to take their medicines. These might include alarms and reminder apps or placing medicines in visible locations...
Too many people are taking way too much Vitamin B6. A senior pharmacist explains the risks of high doses, and how the TGA is responding.
Tobacco use is the leading cause of preventable morbidity and mortality in Australia and worldwide.
Turlington's Balsam was pitched as a veritable ‘cure-all’ in the 18th century – and remains on collectors’ shelves today.
